ginseng C,E
Food supplement declared in France, declaration No 2019-7-4
ginseng C,E is a food supplement declared in France. Status: retiré du marché le 25 April 2025. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.
- Brand
- not provided
- Food business operator placing the product on the market
- HERA PLANTES
- Status
- Retiré du marché le 25 April 2025
- Form
- Gélule
- Daily dose
- 4 gélules
- Directions for use
- 4 gélules le matin
- Not recommended for (according to the manufacturer)
- Femmes allaitantes, Femmes enceintes, Sous antidiabétiques
Declaration 296349, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
- Information
Retiré du marché le 25 April 2025, according to Compl'Alim.
Source: Compl'Alim, food supplement declarations (France).
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Panax ginseng C.A.Mey. | Racine | Poudre (de plantes séchées ou broyées) | 800 mg |
| Malpighia glabra L. | Fruit | Extrait sec alcoolique | 640 mg |
Vitamins and minerals
Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).
| Declared form | Nutrient | EFSA limit, adults | Maximum dose in France |
|---|---|---|---|
| Riboflavine | Vitamine B2 (riboflavine) | pas de limite (données insuffisantes) | dose annulée par le Conseil d'État en 2011 |
| D-alpha-tocophérol | Vitamine E | 300 mg | 30 mg |
Other ingredients
Gélule végétale
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Label warnings
A conserver dans un endroit sec et à l’abrit de la Lumière, hors de portée des enfants. A prendre dans le cadre d’un mode de vie sain. Déconseillé chez les personnes sous traitement antidiabétique. Les femmes enceintes et allaitantes doivent préalablement consulter un professionnel de santé avant toute complémentation.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.